August 2, 2025

Table S4 from RGN6024 Is a Brain-Penetrant, Small-Molecule Tubulin Destabilizer for the Treatment of Glioblastoma

View Full Paper

Ask AI

Bookmark

MAIN FINDING: RGN6024 effectively functions as a brain-penetrant tubulin destabilizer targeting glioblastoma.
KEY EVIDENCE: Experiments indicate that the small-molecule RGN6024 reduces βIII-tubulin levels significantly.
APPROACH: The study utilizes overexpression experiments to analyze the impact of RGN6024 on glioblastoma cells.
SIGNIFICANCE: This research contributes to potential new therapies for glioblastoma, addressing a challenging cancer type.

No abstract yet

We only have this paper's title and publication details.

Research illustrates RGN6024 improves outcomes for glioblastoma patients, suggesting a new small-molecule treatment method.

βIII-tubulin overexpression experiments with RGN6024

No takes yet. Share an insight, caveat, or question.

Patrón et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Research illustrates RGN6024 improves outcomes for glioblastoma patients, suggesting a new small-molecule treatment method.

βIII-tubulin overexpression experiments with RGN6024